These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10610154)

  • 1. Numbers needed to treat derived from meta-analysis. Using patient years may also be misleading.
    Hopayian K; McGough J
    BMJ; 1999 Oct; 319(7218):1199-200. PubMed ID: 10610154
    [No Abstract]   [Full Text] [Related]  

  • 2. Numbers needed to treat derived from meta analysis. NNT is a tool, to be used appropriately.
    Moore A; McQuay H
    BMJ; 1999 Oct; 319(7218):1200. PubMed ID: 10610155
    [No Abstract]   [Full Text] [Related]  

  • 3. Numbers needed to treat derived from meta-analysis. Length of follow up is poorly reported.
    D'Amico R; Deeks JJ; Altman DG
    BMJ; 1999 Oct; 319(7218):1200. PubMed ID: 10610156
    [No Abstract]   [Full Text] [Related]  

  • 4. Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading.
    Smeeth L; Haines A; Ebrahim S
    BMJ; 1999 Jun; 318(7197):1548-51. PubMed ID: 10356018
    [No Abstract]   [Full Text] [Related]  

  • 5. Numbers needed to treat derived from meta-analysis. Are an absurdity.
    Charlton BG
    BMJ; 1999 Oct; 319(7218):1199. PubMed ID: 10541527
    [No Abstract]   [Full Text] [Related]  

  • 6. How should the efficacy of novel treatments be assessed in survival trials?
    Owen A
    Int J Cardiol; 2007 Sep; 120(3):297-300. PubMed ID: 17376549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple logical solution to eliminate the limitations of using the number needed to treat.
    Lui KJ
    Eval Health Prof; 2004 Jun; 27(2):206-14. PubMed ID: 15140295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of a single clinical trial-is it sufficient information?].
    Cucherat M
    Rev Prat; 2000 Apr; 50(8):846-50. PubMed ID: 10874861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias of estimates of the number needed to treat.
    Duncan BW; Olkin I
    Stat Med; 2005 Jun; 24(12):1837-48. PubMed ID: 15806616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numbers needed to treat derived from meta-analysis: a word of caution.
    Marx A; Bucher HC
    ACP J Club; 2003; 138(2):A11-2. PubMed ID: 12614141
    [No Abstract]   [Full Text] [Related]  

  • 11. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.
    Hutton JL
    Br J Haematol; 2009 Jun; 146(1):27-30. PubMed ID: 19438480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based dermatology: number needed to treat and its relation to other risk measures.
    Manriquez JJ; Villouta MF; Williams HC
    J Am Acad Dermatol; 2007 Apr; 56(4):664-71. PubMed ID: 17367615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.
    Sweeting MJ; Sutton AJ; Lambert PC
    Stat Med; 2004 May; 23(9):1351-75. PubMed ID: 15116347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses.
    Brok J; Thorlund K; Wetterslev J; Gluud C
    Int J Epidemiol; 2009 Feb; 38(1):287-98. PubMed ID: 18824466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Numbers needed for treatment and their respective confidence intervals: useful tools to assess clinical significance and uncertainty associated with medical interventions].
    Sampaio C; Ferreira J; Costa J
    Rev Port Cardiol; 2000 Dec; 19(12):1303-8. PubMed ID: 11220124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the meta-analysis of cluster randomized trials.
    Donner A; Klar N
    Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of transforming measures of efficacy for acute therapies: 5-HT agonists as a worked example.
    Fox AW; Keywood C; Sheftell FD; Spierings EL
    Headache; 2004 Jan; 44(1):48-52. PubMed ID: 14979883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size of treatment effects and their importance to clinical research and practice.
    Kraemer HC; Kupfer DJ
    Biol Psychiatry; 2006 Jun; 59(11):990-6. PubMed ID: 16368078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of summary survival curve data.
    Arends LR; Hunink MG; Stijnen T
    Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size isn't everything.
    Hampton JR
    Stat Med; 2002 Oct; 21(19):2807-14. PubMed ID: 12325096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.